Big pharmaceutical companies insists that production of coronavirus vaccines is complicated and can’t be ramped up by easing intellectual property protections.
World mulls next step after U.S. supports waiving COVID-19 vaccine patents
Big pharmaceutical companies insists that production of coronavirus vaccines is complicated and can’t be ramped up by easing intellectual property protections.